A new antitumour substance, 7-oxabicyclo (2.2.1)-5-heptene-2,3-dicarboxylic anhydride.

doi:10.1016/0277-5379(82)90078-5

Paper

A new antitumour substance, 7-oxabicyclo (2.2.1)-5-heptene-2,3-dicarboxylic anhydride.

Published Aug 1, 1982 · I. R. Shimi, Z. Zaki, S. Shoukry

European journal of cancer & clinical oncology

UNKNOWN SJR score

15

Citations

4

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Study Snapshot

7-Oxabicyclo (2.2.1)-5-heptene-2,3-dicarboxylic anhydride shows antitumor activity against Ehrlich ascites carcinoma cells, decreasing viable counts and cell proliferation, and increasing survival in mice.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

A new antitumour substance, 7-oxabicyclo (2.2.1)-5-heptene-2,3-dicarboxylic anhydride.

References

Citations